Published in Autoimmunity on May 01, 2006
Myositis-related interstitial lung disease and antisynthetase syndrome. J Bras Pneumol (2011) 1.38
The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis. Ann Rheum Dis (2012) 1.15
Characterization and peripheral blood biomarker assessment of anti-Jo-1 antibody-positive interstitial lung disease. Arthritis Rheum (2009) 1.08
Survival analysis of patients with dermatomyositis and polymyositis: analysis of 192 Chinese cases. Clin Rheumatol (2011) 0.96
Interstitial lung disease in polymyositis and dermatomyositis. Clin Rheumatol (2009) 0.96
Antisynthetase syndrome: a case report. Quant Imaging Med Surg (2016) 0.75
Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) (2003) 4.00
Glucocorticoid receptor beta splice variant expression in patients with high and low activity of systemic lupus erythematosus. Folia Histochem Cytobiol (2007) 0.87
Anti-influenza vaccination in systemic lupus erythematosus patients: an analysis of specific humoral response and vaccination safety. Clin Rheumatol (2010) 0.85
Perceived work-related stress and early atherosclerotic changes in healthy employees. Int Arch Occup Environ Health (2008) 0.83
[Prevalence of autoantibodies directed against 1,25(OH)2D3 in patients with systemic lupus erythematosus]. Pol Merkur Lekarski (2010) 0.81
Serum concentration of interleukin 15, interleukin 2 receptor and TNF receptor in patients with polymyositis and dermatomyositis: correlation to disease activity. Rheumatol Int (2010) 0.81
Clinical manifestation of systemic lupus erythematosus in patients with antiribosomal P protein antibodies. Pol Arch Med Wewn (2010) 0.79
PTPN22/LYP 1858C>T gene polymorphism and susceptibility to endometriosis in a Polish population. J Reprod Immunol (2009) 0.79
[Evaluation of systemic lupus erythematosus activity during pregnancy]. Pol Arch Med Wewn (2007) 0.77
[New markers of autoimmunity against joints and salivary glands in HCV infected patients]. Przegl Epidemiol (2005) 0.75
[Antiphospholipid syndrome (APS) primary (PAPS) and secondary (SAPS)]. Pol Arch Med Wewn (2006) 0.75
IL-10, IL-12B and IL-17 gene polymorphisms in patients with mixed connective tissue disease. Mod Rheumatol (2014) 0.75
[Biological therapies of systemic lupus erythematosus]. Pol Merkur Lekarski (2006) 0.75
[The Polish Task Force position statement on safety of biologic treatment with monoclonal antibodies and soluble receptors]. Pol Merkur Lekarski (2014) 0.75
[Different diagnosis:Lyme arthritis or rheumatoid arthritis]. Przegl Epidemiol (2006) 0.75
[The occurrence of anticardiolipin antibodies bound in circulating immunological complexes in sera of patients suffering from juvenile lupus erythematosus and juvenile idiopathic arthritis]. Pol Arch Med Wewn (2008) 0.75
[Variety of initial symptoms in patients with Wegener's granulomatosis]. Pol Merkur Lekarski (2004) 0.75
[Lyme carditis--a bitter lesson or a delayed diagnostic success--a case report]. Kardiol Pol (2007) 0.75
[Presence of anticardiolipin antibodies in cryoglobulins isolated from sera of hepatitis C virus infected patients]. Pol Arch Med Wewn (2008) 0.75
[Antiphospholipid antibodies and antiphospholipid syndrome in juvenile lupus erythematosus]. Pol Arch Med Wewn (2006) 0.75
[Symptoms and signs of polymositis, systematic lupus erythematosus and antiphospholipid syndrome follow consecutively]. Pol Arch Med Wewn (2008) 0.75
[Preliminary studies on presence of antineuronal antibodies in serum of patients with Lyme borreliosis]. Przegl Epidemiol (2006) 0.75